Nordoxepin, Urine
Melanoma, FISH, Tissue
Growth Hormone Binding Protein (GHBP)
IsoPSA Test
Glomerular Filtration Rate, Estimated (eGFR)
Interleukin 28 B (IL28B) Gene Variation Analysis
Apolipoprotein A1
HLA C Genotype
Hereditary Colon Cancer Gene Mutation Panel (Lynch syndrome), NGS
MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Additional Testing
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now